NEWS RELEASE
VANCOUVER, British Columbia – Roadman Investments Corp. (TSXV: LITT)(FWB: 1QD) (“Roadman Investments” or the “Company”) is pleased to announce that Alisa Manion has joined the company’s board of directors and that Alexzander Samuelsson has resigned from the board.
Ms. Manion begun her biology career studying Biomedical Sciences in Guelph, Ontario and received her Bachelor of Science degree in Cell Biology and Genetics from the University of British Columbia in 2013. Her specialized knowledge, technical skills as well biological research and laboratory expertise will be an asset to Roadman.
Some of Ms Manion’s experience includes:
- Researcher at the BC Children’s hospital injury research and prevention unit;
- Completed an intensive directed study in spinal cord injuries at Blusson Spinal Cord Centre under the Director of ICORD (focus on stem cell transplantation, regeneration and injury recovery);
- VP at Canadian Liver Foundation UBC Chapter;
- Volunteered as a Big Sister; and
- 5 years as a Financial Advisor with IG Wealth Management working with nurses, doctors, and other STEM based clients.
Alisa is actively involved in latest health research due to personal diagnosis with a genetic autoimmune disease and is also very passionate about the potential psychedelics pose for mental health. She has personally studied numerous scientific papers on the efficacy of MDMA and psilocybin in treatment of PTSD, anxiety and depression. This experience will assist the Company in evaluating start-up companies in this budding industry.
Luke Montaine, Chief Executive Officer and a Director of Roadman Investments states, “Alisa’s biology background will allow us to move forward our health and wellness initiatives much more efficiently. Her personal interest and passion for health and wellness and her financial services experience make her a perfect fit for our team.”
Roadman would also like to announce that Alexzander Samuelsson has resigned from the board. We would like to thank Mr. Samuelsson for his service and wish him the best on his future endeavours.
About Roadman Investments
Roadman Investments is a Canadian Venture Capital and Advisory Firm that strives to actively drive innovation and accelerate growth within its portfolio holdings. Roadman invests capital into companies that offer breakthrough products, devices, treatments and health supplements.
For further information please contact:
Luke Montaine CEO,
Director Roadman Investments Corp.
604-760-8755
Luke@rightseasoninvestmentscorp.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This press release contains “forward-looking statements” within the meaning of applicable securities laws. Forward-looking statements can be identified by any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as “expects” or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “estimates” or “intends”, or stating that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved), and variations of such words, and similar expressions are not statements of historical fact and may be forward-looking statements. Examples of forward-looking statements include, among others, statements we make about the Company, its subsidiaries or other Company’s that the Company has invested in or is otherwise affiliated with, regarding planned research and development activities, financing arrangements, investment strategies, returns on investments, contractual obligations including but not limited to obligations to purchase materials or meet sales milestones, strategy for customer retention, growth, product development, market position, financial results and reserves, other statements relating to the financial and business prospects, management’s ability it identify and evaluate investments, management’s ability to obtain the necessary funding or obtain the necessary licenses and approvals to operate, specifically, the necessary licenses and approvals to open any such facilities in California or the United States of America.
Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: economic and financial conditions, including volatility in interest and exchange rates, commodity and equity prices and the value of financial assets, continued volatility in the capital or credit markets the adequacy of our cash flow to fund the operations of the Company or its affiliates, strategic actions, including acquisitions and dispositions and our success in evaluating acquired businesses and our success in developing the businesses underlying these acquisitions, the occurrence of hostilities, political instability or catastrophic events, changes in customer demand, the extent to which we are successful in gaining new long-term relationships with customers or retaining existing ones and the level of service failures that could lead customers to use competitors’ services, developments and changes in laws and regulations, including increased regulation of the medical, health and wellness industries through legislative action and revised rules and standards applied by the international medical, pharmaceutical, health and wellness regulatory bodies, changes in the price of inventory and other key materials and disruptions in supply chains for these materials, closures or slowdowns and changes in contracted service provider costs and labor difficulties, including stoppages affecting either our operations or our service providers abilities to conduct research and develop and produce products, management’s ability to operate our business models, availability of financing to provide sufficient working capital maintain the business as a going concern, availability of financing to fund the Company’s or it is subsidiaries business operations, including but not limited to, meeting the Company’s obligations under the agreement with Psychedelic insights, compliance and approvals under the appropriate State and Federal laws and other factors as discussed in the Company’s filings with Canadian securities regulators, which are available at www.sedar.com. Investors are cautioned that forward-looking statements are not guarantees of future performance or events and, accordingly are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements. The forward-looking statements included in this news release are made as of the date hereof and the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities legislation. This news is not for dissemination in the United States of America.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.